Early prophylactic tx beneficial for hypertrophic cardiomyopathy

September 10, 2012
Early prophylactic tx beneficial for hypertrophic cardiomyopathy
Beta blockers are effective as an early prophylactic pharmacologic treatment for patients with mild hypertrophic cardiomyopathy who have exercise-induced left ventricular outflow tract obstruction, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.

(HealthDay)—Beta blockers (BBs) are effective as an early prophylactic pharmacologic treatment for patients with mild hypertrophic cardiomyopathy (HC) who have exercise-induced left ventricular outflow tract (LVOT) obstruction, according to a study published in the Sept. 1 issue of The American Journal of Cardiology.

Stefano Nistri, M.D., Ph.D., of CMSR-Veneto Medica in Vicenza, Italy, and associates examined the benefits of BBs in a prospective study involving 27 patients with HC with mild or no symptoms of , without obstruction at rest, but with exercise-induced LVOT gradients of ≥30 mm Hg.

The researchers found that the mean post-exercise LVOT gradient was 87 ± 29 mm Hg. After an average of 12 months of BB treatment with or bisoprolol, the post-exercise LVOT gradient decreased significantly and was almost abolished in 52 percent of patients (0 to <30 mm Hg), considerably reduced in 33 percent (≥20 mm Hg reduction), and unchanged in 15 percent. Severe post-exercise obstruction persisted in 22 percent of treated patients, compared with 93 percent of untreated patients. Body mass index was increased among non-responders (hazard ratio, 2.03 per 1 kg/m²).

"In patients with HC with mild or no symptoms, treatment with BBs can prevent the development of LVOT obstruction triggered by physiologic exercise," the authors write. "These findings provide a rationale for the novel strategy of early prophylactic pharmacologic treatment with standard, well-tolerated doses of BBs in physically active patients with provocable gradients, aimed at effective prevention of the hemodynamic burden associated with dynamic obstruction."

Explore further: Good transplant outcomes in hypertrophic cardiomyopathy

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Good transplant outcomes in hypertrophic cardiomyopathy

August 17, 2012

(HealthDay) -- Post-heart transplant survival does not differ significantly between patients with hypertrophic cardiomyopathy (HC) and those with other types of heart disease, according to a study published in the Aug. 15 ...

BMI, post-exercise knee laxity change tied to OA progression

August 21, 2012

(HealthDay) -- In patients with osteoarthritis (OA) of the knee, changes in knee joint laxity during stair climbing or other repetitive physical activity and baseline body mass index (BMI) are associated with disease progression, ...

Recommended for you

Scientists identify protein linked to chronic heart failure

May 26, 2017

Researchers in Japan have identified a receptor protein on the surface of heart cells that promotes chronic heart failure. The study, "Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction," which ...

Hypertension in young adults shows long-term heart risks

May 19, 2017

Otherwise healthy young people with high systolic blood pressure over 140 are at greater risk for future artery stiffening linked to an increased risk of stroke as well as possible damage to the kidneys and brain, new research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.